4
Changes in Ownership
AYTU BIOPHARMA, INC Filed Acc 0001437749-25-010224
Chief Commercial Officer acquired 209 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PYSZCZYMUKA GREG · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-31 | Exercise or conversion : show line 1 in the form | +209 | 23,602 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-31 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −209 | 0 | D |
Loading xslF345X05/rdgdoc.xml…